Brian Corvese - 17 Jun 2025 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Director
Signature
/s/Christine Klaskin, as Attorney-in-Fact for Brian Corvese
Issuer symbol
AGEN
Transactions as of
17 Jun 2025
Transactions value $
$0
Form type
4
Filing time
20 Jun 2025, 16:10:04 UTC
Previous filing
04 Jun 2025
Next filing
03 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Corvese Brian Director C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON /s/Christine Klaskin, as Attorney-in-Fact for Brian Corvese 20 Jun 2025 0001393207

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGEN Stock Option Award $0 +750 $0.00 750 17 Jun 2025 Common Stock 750 $3.02 Direct F1
transaction AGEN Stock Option Award $0 +30K $0.00 30K 17 Jun 2025 Common Stock 30K $3.02 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options were granted on May 28, 2025 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 17, 2025. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on May 28, 2026, and the balance vesting in equal quarterly installments thereafter.
F2 Options were granted on May 28, 2025 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 17, 2025. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests on the one-year anniversary of the grant date.